ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

H1N1 Swine Flu Update - Guillain Barre Syndrome & Other Vaccine Fallout

Updated on November 28, 2009

The Centers For Disease Control & Prevention is expecting to release this report early in December and the virological and medical community is looking forward to this issuance as it will mark a turning point in the epidemiological research of H1N1. This report will give researchers a much better indication of what is occurring out in the field with H1N1 Mexican Swine Flu Virus and therefore, how to best counteract it.

With the limited data which has been collected to this point there are no unusual signals or strange adverse occurrences connected with either the seasonal vaccine for influenza or the specific vaccine against H1N1 that would be of a severity which would prompt the Centers for Disease Control and Prevention in Atlanta to recommend that interventions be taken urgently.

However the Centers For Disease Control & Prevention continues to monitor the situation on a minute by minute basis and turn over information on every event for evaluation to the Centers For Disease Control & Prevention's and National Institutes Of Health's clinical personnel in order to discover new patterns in the H1N1 virus's behaviour.

The Center for Disease Control & Prevention also has a variety of clinical system monitors in place that are actively seeking signs that the vaccine exposure has been directly responsible for various conditions which can be considered severe such as Guillain Barre Syndrome. The details are not yet unfortunately available but hopefully those details will be available in their full clinical version in the beginning of December 2009.

The surveys which have been conducted by various news organizations and medical organizations in the United States have been showing that the interest in vaccination among individuals in the target population has been steadily increasing and that parents are becoming more and more convinced that their children should be vaccinated. The single greatest problem facing vaccination acceptance in the United States is the concern by people who do not believe that the disease is not serious and will be believe that the vaccine may be unsafe.

The recent information from the Canadian Medical Health Authorities that a number of individuals who have received the H1N1 vaccine in that country have suffered severe allergic reactions as well as side effects and after effects from the administration of the vaccine have not yet been finalized. Therefore it cannot be determined as to whether the source of those ill effects are from the elements of the vaccine which is shared in common with the one used in the United States or whether it is a different form of vaccine that is used in Canada which is based on a adjuvanted formula. Again that information should be available in December.

The fact remains that a particular batch of H1N1 Mexican Swine Flu Virus vaccine that was shipped from Glaxo Smith Kline to various provinces in Canada has proven to cause a higher than average rate of reactions in the individuals who received that vaccine. The form of reaction is anaphylaxis and one man who had received a pandemic influenza H1N1 vaccine shot died shortly thereafter from anaphylaxis reaction. Investigations are currently being conducted by the Canadian government and Glaxo Smith Kline officials while the entire lot of vaccine has been destroyed. The lot consisted of 125,000 doses which were shipped to total of 6 Canadian provinces.

Continued In H1N1 Swine Flu Update - Canadian Vaccine & Anaphylaxis

Back To Start


Disclaimer: The information on this Hub page does not constitute medical, legal, commercial, product, and/or service advice or endorsement of any vendor, supplier and/or brand, and does not necessarily reflect the opinion of the author. Listing of an entity or service on this Hub page is not a warranty of the quality or efficacy of the products or services furnished by any entity. The author is not directly compensated by any entity other than the advertising placement services shown on this page.


    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)